So, Capmatinib is this nifty little inhibitor thing that zeroes in on the MET receptor, you know, those tyrosine kinase things. It’s like a superpower for battling that really tough lung cancer, the kind where it spreads all over the place and there’s this specific glitch in the cancer’s code called MET exon 14 skipping mutations. You can get this stuff in two types of tablets, kind of like different flavors, with 150 mg or 200 mg doses.
You’re supposed to take 400 mg of this daily, split into two doses, and it doesn’t matter if you take it with food or not. These pills come in bottles that hold 60 of them. The magic in these pills is capmatinib, a tiny molecule that stops that MET pathway thingie in its tracks.
It’s like shutting off the cancer’s growth and spread engine.
